Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Articles published by Aridis Pharmaceuticals, Inc.
(Updated) Aridis Pharmaceuticals Receives Equity Investment from the Cystic Fibrosis Foundation
December 12, 2022
From
Aridis Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
ARDS
Aridis Pharmaceuticals Receives Equity Investment from the Cystic Fibrosis Foundation
December 12, 2022
From
Aridis Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
ARDS
Aridis Signs Exclusive Terms to Secure Worldwide Commercial Licenses for Pan-Ebola and Pan-Marburg Monoclonal Antibody Programs from Mapp Biopharmaceutical
December 05, 2022
From
Aridis Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
ARDS
Aridis Announces a Key Milestone of Closing of Patient Enrollment in the Phase 2a Study of AR-501 in Cystic Fibrosis Patients
November 30, 2022
From
Aridis Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
ARDS
Aridis to Participate in Key Opinion Leader Discussion on Immunotherapy for Infectious Diseases
November 22, 2022
From
Aridis Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
ARDS
Aridis Pharmaceuticals Announces Third Quarter 2022 Financial Results and Business Update
November 21, 2022
From
Aridis Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
ARDS
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.